Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages

INTRODUCTION: The mortality of rhabdomyolysis-induced acute kidney injury (AKI) is still high, as there is no effective therapy. It has been shown that bone marrow-derived mesenchymal stem cells (MSCs) can induce M2 macrophages, which mediate MSC protection in other experimental inflammation-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Yanqiu, Zhang, Li, Fu, Bo, Zhang, Jianrong, Hong, Quan, Hu, Jie, Li, Diangeng, Luo, Congjuan, Cui, Shaoyuan, Zhu, Fei, Chen, Xiangmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230233/
https://www.ncbi.nlm.nih.gov/pubmed/24961539
http://dx.doi.org/10.1186/scrt469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230233/
https://www.ncbi.nlm.nih.gov/pubmed/24961539
http://dx.doi.org/10.1186/scrt469

Ejemplares similares